Login
Résultat de la recherche (1-20 par 114)Download
|
Symbol
|
RMBWZV | RMAMHV | RMA0EV | CYXCBL | AABYTQ | OJKRCH | AACATQ | OKYRCH | AAGITQ | OPJRCH | CDKBKB | KYOTDU | OSLRCH | RMAJ7V | OZARCH | OWRRCH | ABCVTQ | RMA6QV | KYXXDU | ABICTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Sous-jacent
|
Novartis AG / Novo Nordisk AS (B) / Sandoz Group AG | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Pfizer Inc. | Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Amgen Inc. / Fresenius SE & Co. KGaA / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Sanofi S.A. | ASML Hldg. N.V. / Novo Nordisk AS (B) / UniCredit S.p.A. | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche AG | ASML Hldg. N.V. / Novo Nordisk AS (B) / Sanofi S.A. | Eli Lilly & Co. / Novo Nordisk AS (B) | Bachem Hldg. AG / Novo Nordisk AS (B) / Tecan Group AG | ASML Hldg. N.V. / Novo Nordisk AS (B) / SAP SE | Eli Lilly & Co. / Merck & Co. Inc. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche AG | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche AG | Eli Lilly & Co. / Merck & Co. Inc. / Novo Nordisk AS (B) | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
16.03.2026 | 02.03.2026 | 15.06.2026 | 17.12.2025 | 17.12.2025 | 17.12.2025 | 17.12.2025 | 24.12.2025 | 12.01.2026 | 26.01.2026 | 26.02.2026 | 16.02.2026 | 19.08.2026 | 20.03.2026 | 07.04.2026 | 20.03.2026 | 07.01.2026 | 27.03.2026 | 09.04.2026 | 05.05.2026 |
| Demande | 43,900 | 36,900 | - | - | 34,680 | 33,310 | - | 33,190 | 33,590 | - | 36,310 | 39,050 | 38,710 | 36,400 | 43,490 | - | 42,190 | 39,600 | 52,00 | 45,160 |
| Offre | - | - | - | - | - | - | - | - | - | - | - | 40,050 | - | - | - | - | - | - | 53,00 | - |
S'il vous plait attendre
Le push de données de prix a été désactivé en raison d'un timeout. S'il vous plaît cliquez sur "Actualiser la page" pour continuer.
Votre mémo (0)